A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients with Schizophrenia in Japan

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2022
This article has no abstract
Epistemonikos ID: a6ad6e35ddf5247857296447db63a7b4a6f29340
First added on: Apr 11, 2025